Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Venture firm IVP has raised its biggest fund yet at $1.5 billion

A sign of the times.

Snapchat co-founders CTO Bobby Murphy and CEO Evan Spiegel rang the bell at the New York Stock Exchange on the day Snap had its IPO.
Snapchat co-founders CTO Bobby Murphy and CEO Evan Spiegel rang the bell at the New York Stock Exchange on the day Snap had its IPO.
Drew Angerer / Getty

With valuations of private companies climbing higher and higher, some venture capital firms have a simple solution: Larger funds.

IVP, the firm founded 35 years ago that specializes in later-stage investments, on Tuesday said it had raised its largest fund yet — a $1.5 billion pool of money that is their 16th in the venture business.

Some of IVP’s most well-known investments in recent years include Twitter, Slack, Dropbox and Snap, though they tended to invest in those companies after some earlier-stage venture firms had discovered them.

IVP said their ability and eagerness to deploy so much cash showed that the firm was an “island of stability in the midst of the storm.”

“There’s been all kinds of bad publicity about the venture business. Valuations are too high. There’s too much money in the sector. People misbehaving,” Sandy Miller, one of the firm’s general partners, told Recode. IVP’s fund is “basically a validation that this is a healthy environment.”

IVP expects to invest in 35 to 40 companies over the 10-year fund’s lifespan; check sizes range from $10 million to $100 million.

The firm is still awaiting several large exits from some of its prospects. Dropbox is strongly expected to go public either late this year or early next year; Slack’s path toward an IPO was perhaps delayed by the millions it just accepted from SoftBank’s $100 billion Vision Fund.

Miller said, though, that the Vision Fund could be a force for good.

“The Vision Fund is a wild card but could be a significant factor in terms of exits for venture,” he said, explaining that investors have “new vehicles” for liquidity by possibly selling their stakes to SoftBank.

And as for Snap, which has sharply fallen since going public earlier this year?

“We’ve been disappointed with what happened in the public marketplace,” Miller said. “Whatever companies are losing money and have this high a profile — they’re going to be very volatile in the public market. But volatility can go in both directions.”


This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh